Metropolitan Life Insurance Company (MetLife)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-31,111
| Closed | -$106K | – | 2612 |
|
|
2018
Q3 | $106K | Hold |
31,111
| – | – | ﹤0.01% | 2421 |
|
|
2018
Q2 | $117K | Buy |
31,111
+3,465
| +13% | +$13K | ﹤0.01% | 2241 |
|
|
2018
Q1 | $113K | Buy |
27,646
+6,652
| +32% | +$27.2K | ﹤0.01% | 2231 |
|
|
2017
Q4 | $98K | Sell |
20,994
-38,155
| -65% | -$178K | ﹤0.01% | 2323 |
|
|
2017
Q3 | $420K | Buy |
59,149
+286
| +0.5% | +$2.03K | ﹤0.01% | 1803 |
|
|
2017
Q2 | $426K | Buy |
58,863
+9,230
| +19% | +$66.8K | ﹤0.01% | 1819 |
|
|
2017
Q1 | $306K | Sell |
49,633
-14,444
| -23% | -$89.1K | ﹤0.01% | 1986 |
|
|
2016
Q4 | $375K | Buy |
64,077
+3,994
| +7% | +$23.4K | ﹤0.01% | 1922 |
|
|
2016
Q3 | $319K | Sell |
60,083
-15,025
| -20% | -$79.8K | ﹤0.01% | 2015 |
|
|
2016
Q2 | $497K | Hold |
75,108
| – | – | ﹤0.01% | 1704 |
|
|
2016
Q1 | $351K | Buy |
75,108
+874
| +1% | +$4.08K | ﹤0.01% | 1806 |
|
|
2015
Q4 | $375K | Hold |
74,234
| – | – | ﹤0.01% | 1826 |
|
|
2015
Q3 | $261K | Sell |
74,234
-818
| -1% | -$2.88K | ﹤0.01% | 2093 |
|
|
2015
Q2 | $749K | Sell |
75,052
-3,835
| -5% | -$38.3K | 0.01% | 1487 |
|
|
2015
Q1 | $1M | Buy |
78,887
+6,588
| +9% | +$83.8K | 0.01% | 1190 |
|
|
2014
Q4 | $1.02M | Hold |
72,299
| – | – | 0.01% | 1308 |
|
|
2014
Q3 | $994K | Hold |
72,299
| – | – | 0.01% | 1281 |
|
|
2014
Q2 | $1.11M | Hold |
72,299
| – | – | 0.01% | 1286 |
|
|
2014
Q1 | $1.23M | Buy |
72,299
+6,612
| +10% | +$113K | 0.01% | 1203 |
|
|
2013
Q4 | $851K | Hold |
65,687
| – | – | 0.01% | 1446 |
|
|
2013
Q3 | $663K | Hold |
65,687
| – | – | 0.01% | 1562 |
|
|
2013
Q2 | $491K | Buy |
+65,687
| New | +$491K | ﹤0.01% | 1712 |
|